Clinical Studies & Research Solutions
Are you investigating how the latest technology could be used to deliver improved cardiovascular care? Digital cardiac biomarkers can shift the focus from treating complications towards prevention.
Digital cardiac biomarkers
We develop digital cardiac biomarkers for several major heart diseases. We have done robust clinical validation for the gyrocardiography method: Gyrocardiography non-invasively measures chest movements to determine cardiac function. We continue to collaborate with academic institutions to further validate detection capabilities and the usability of digital cardiac biomarkers in clinical practice.
We are currently studying:
Heart failure
Coronary artery disease
Valve disease
Pulmonary artery hypertension
VO2 max
A powerful technology for clinical trials and patient identification
✔ Effective tool in study participant recruitment and identification
✔ A scalable tool to collect vital signs and digital cardiac biomarkers
✔ For clinical drug development, to assess progression and early detection of a disease
✔ Patient engagement to improve retention during a clinical trial
Gyrocardiography: 10+ years of academic research
CardioSignal is originally an academic spinoff. Our patented gyrocardiography technology has been documented in over 20 peer-reviewed publications. See a list of our selected publications.
Contact us
We partner with academic institutions and biopharma companies to search for new ways to improve patient outcomes in heart disease.
Contact our medical team cardiologist Juuso Blomster, MD, PhD, juuso.blomster@cardiosignal.com or Tero-Pekka Alastalo, MD, PhD tpa@cardiosignal.com (North America operations).